Commonwealth Equity Services
VYGR icon

Commonwealth Equity Services’s Voyager Therapeutics VYGR Stock Holding History

Commonwealth Equity Services’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41K Buy
11,704
+400
+4% +$1.52K ﹤0.01% 4320
2026
Q1 		$43.6K Buy
11,304
+50
+0.4% +$197 ﹤0.01% 4212
2025
Q4 		$44.2K Sell
11,254
-5,223
-32% -$23.1K ﹤0.01% 4193
2025
Q3 		$77K Sell
16,477
-19,473
-54% -$70.4K ﹤0.01% 4123
2025
Q2 		$112K Sell
35,950
-31,374
-47% -$101K ﹤0.01% 4046
2025
Q1 		$228K Buy
67,324
+1,294
+2% +$6.04K ﹤0.01% 3730
2024
Q4 		$374K Sell
66,030
-2,900
-4% -$18.7K ﹤0.01% 3219
2024
Q3 		$403K Sell
68,930
-8,975
-12% -$65.3K ﹤0.01% 3088
2024
Q2 		$616K Buy
77,905
+20,950
+37% +$176K ﹤0.01% 2659
2024
Q1 		$530K Buy
+56,955
New +$481K ﹤0.01% 2770
2023
Q2 		– Sell
-18,000
Closed -$138K – 3934
2023
Q1 		$138K Sell
18,000
-5,500
-23% -$43.7K ﹤0.01% 3431
2022
Q4 		$143K Sell
23,500
-834
-3% -$4.74K ﹤0.01% 3338
2022
Q3 		$144K Hold
24,334
– – ﹤0.01% 3293
2022
Q2 		$143K Buy
+24,334
New +$164K ﹤0.01% 3300
2019
Q2 		– Sell
-13,374
Closed -$255K – 2819
2019
Q1 		$255K Buy
13,374
+815
+6% +$10.6K ﹤0.01% 2284
2018
Q4 		$118K Sell
12,559
-2,013
-14% -$25.8K ﹤0.01% 2464
2018
Q3 		$275K Sell
14,572
-1,700
-10% -$32.6K ﹤0.01% 2245
2018
Q2 		$318K Buy
16,272
+3,500
+27% +$69.2K ﹤0.01% 2063
2018
Q1 		$239K Sell
12,772
-11
-0.1% -$238 ﹤0.01% 2256
2017
Q4 		$212K Buy
+12,783
New +$219K ﹤0.01% 2324

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Commonwealth Equity Services's VYGR Position: Q2 2026 in Review

Commonwealth Equity Services increased its Voyager Therapeutics (VYGR) stake by 3.5% in Q2 2026, buying an estimated $1.52K and bringing the position to 11,704 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #4320.

Commonwealth Equity Services first reported a position in VYGR in Q4 2017 and has held it in 20 quarters since. The position peaked at $616K in Q2 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Commonwealth Equity Services held 11,704 shares of Voyager Therapeutics worth $41K as of Q2 2026.
  • Commonwealth Equity Services bought 400 Voyager Therapeutics shares in Q2 2026, an estimated $1.52K.
  • Voyager Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4320 holding.
  • Commonwealth Equity Services first reported a position in Voyager Therapeutics in Q4 2017 and has held it in 20 quarters since.
  • Commonwealth Equity Services's Voyager Therapeutics position peaked at $616K in Q2 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.